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 AIM AND OBJECTIVE OF THE STUDY 
 
1. To statistically analyse the incidence of cancer cervix at Coimbatore    
     Medical  College Hospital.  
2. To establish the role of AgNORs in differentiating the benign from the                           
      pre- malignant and the malignant lesions of the cervix. 
3. To establish the grade of malignancy according to the AgNOR count. 
4. To evaluate the utility of AgNOR count as a diagnostic and prognostic        
    marker in malignancies of uterine cervix.   
5. To plan treatment in cases of carcinoma cervix by using AgNOR count    
    as a prognostic tool.     
6. To assess AgNOR count in different types of cervical cancer. 
 
 
 
 
  
INTRODUCTION 
In the female genital tract the cervix is the most common site 
exposed to both bacterial and viral infection. It is also the target for 
agents which are carcinogenic   leading to invasive cancer. 
   According to worldwide  cancer statistics cervical carcinoma is the 
second most common cancer in women .Almost fifty percentage of the 
reported new cases every year have been proved to be fatal. The declining 
cervical cancer rates are due to accurate histologic interpretation of 
biopsy specimens by the pathologist and effective Papanicolaou (Pap) 
smear screening programs 
1
. 
Routine cytological Papanicolaou (Pap) smear screening, early 
diagnosis and curative therapy has reduced the mortality rate of cervical 
cancer. Pre-invasive lesions which can progress to invasive cancer have 
been detected and treated earlier by effective screening programs.     
All features which are of diagnostic and prognostic significance are 
not revealed by routine histopathological techniques. This was due to the 
difficulties in differentiating the malignant aberrations from the benign 
ones microscopically.  
 Therefore, it was essential to develop adjunct procedures which can 
diagnose malignancy with accuracy and at the earliest.  
Studies have showed that there is a definite correlation between 
nucleolar function, size and the cell doubling time in human cancer cell 
lines. This concept 
2
   has stimulated a revolution of the significance of 
the nucleus in tumour pathology. 
Cellular proliferative activity can be assessed by a variety of tests. 
The method of counting mitosis can detect only major differences in the 
proliferation of tumour tissue .The procedure of counting mitotic activity 
is time consuming and also technically difficult. 
The disadvantage of flow cytometry is that the tissue is destroyed 
by the process and it is difficult to evaluate the normal cell population 
admixed with the cancer cells. This method calculates the percentage of 
dividing cells by S-Phase fraction.  
Markers of cell proliferation like Ki-67, DNA polymerase, PCNA 
(proliferating cell nuclear antigen) can be demonstrated using 
immunohistochemical methods. But the procedure is expensive and 
complicated. 
Staining of the nucleolar organising regions by silver compound 
(AgNOR) has gained popularity for its simplicity and easy procedure. It 
is of low cost and has good correlation with other proliferative markers. 
              In proliferating cells, concurrent to the increased synthesis of 
AgNOR proteins, there is progressive dispersal of ribosomal chromatin, 
whereas in resting  cells ribosomal sequences are located in highly 
compact structured chromatin. 
The frequency of AgNOR count within nucleus are significantly 
higher in malignant cells than in normal, reactive or benign cell 
3,4
. 
This is a prospective study to see if quantification of AgNOR could 
help in distinguishing between inflammatory, dysplastic and malignant 
lesions of the cervix. 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
ANATOMY  
 The cervix is located in the lower part of the uterus. It connects the 
uterine cavity to the vagina and a narrow cervical canal passes through it.  
Ectocervix is the outer surface of the vaginal portion of cervix and 
endocervix is related to the endocervical canal .The external os is the 
opening of the endocervical canal into the vagina. Internal os, is the 
imprecise upper limit of the endocervical canal .
5
 
HISTOLOGY :- 
Histologically cervical canal is lined by mucus secreting columnar 
epithelium .It also lines the endocervical glands. In the portio vaginalis 
the columnar epithelium changes abruptly to non –keratinized squamous 
epithelium. The connective tissue in the lamina propria of cervix is more 
fibrous than in the uterus. Blood vessels, smooth muscles, elastic tissue, 
nerves and occasional lymphatic nodules may be seen. 
Smooth muscle fibres are located mainly in the endocervix. It is 
usually absent in the vaginal portion of cervix. 
Sphinctric action at the isthmus is provided by the smooth muscles 
arranged concentrically which constitutes about 50-60% of the supporting 
connective tissue.     
               Most of the exocervix is covered by non-keratinizing squamous 
epithelium that in child bearing age is composed of three layers basal cell, 
mid zone and superficial. The real stem cells of the cervical squamous 
mucosa are located in the parabasal layer according to some authors.            
A layer of mucus- secreting columnar cells lines the glandular mucosa of 
the endocervix. This cell  which rest on a inconspicuous  subcolumnar “ 
reserve” cell located at are near the squamous columnar junction, are 
primarily involved in the process of squamous metaplasia , Cervical 
Intraepithelial Neoplasia  & carcinoma. 
 
INFLAMMATORY LESIONS OF CERVIX 
 
INFECTIOUS CERVITIS: 
           The organism most commonly causing active inflammation of the 
cervix includes bacteria, virus, fungi, protozoa and parasites. Infections 
frequently seen are due to Candida albicans, Trichomonas vaginalis, 
Gardenrella vaginalis, Human papilloma virus and Herpes simplex virus. 
The squamous epithelium of the cervix is a site of predeliction for 
the infectious viral agents causing changes in the morphology of the cells 
which are characteristic. 
         Causes of non-specific cervicitis not of infectious etiology may be 
chemical or mechanical in nature. They include tampons, diaphragm, 
pessaries and IUCD which are foreign bodies causing local trauma. 
Round cells which includes lymphocytes, plasma cells and histiocytes 
predominates the inflammatory infiltrate in chronic cervicitis. 
          The morphological changes seen in association with inflammatory 
lesions of cervix often cause serious problems in distinguishing from 
genuine atypia .But the changes in cervicitis are usually mild without 
reduction in cytoplasm or increase in mitotic activity. 
 
REGENERATING / HEALING EPITHELIUM 
       Reactive changes can occur in the epithelium due to erosion of cervix 
by chronic persistent infection .It is also seen in epithelial injury caused 
by biopsy or conization procedures. The morphological changes are 
characterized by epithelial disorganization and nuclear atypia seen in 
squamous and endocervical epithelium. 
      Histologically and cytologically these reactive changes often mimics 
Intra Epithelial Neoplasia.   In reactive atypia the nuclei are uniform in 
shape and size, well defined cytoplasmic membrane, clumped chromatin 
and normal mitotic figures. 
ATROPHY: 
Hormone deficiency in peri-menapausal, post-menapausal or pre-
pubertal states causes alteration in maturation of the squamous 
epithelium. The changes include uniform basal and parabasal cells with 
an increased nuclear cytoplasmic ratio, dense chromatin, pleomorphism 
and rare mitosis. 
Epithelial changes seen in the atropic mucosa are sometimes 
difficult to differentiate from squamous Intraepithelial Neoplasia. 
 
ATYPIA RELATED TO THERAPY:- 
Therapeutic level of radiation used in the treatment of cervix can 
cause morphological changes in both squamous and glandular 
epithelium.These changes can be acute or chronic. 
Radiation effects are variable degrees of epithelial atypia and 
enlarged nuclei but mitotic figures are absent. Stromal changes include 
presence of fibrosis, atypical fibroblast and multinucleated cells.  
             
 
 
MALIGNANT LESIONS OF CERVIX 
PRECANCEROUS DISEASE 
 Squamous Intra epithelial Neoplasia 
           The zone of epithelial transformation is the site for all squamous 
alteration to occur referred to as CIN (Cervical Intra Epithelial Neoplasia)    
           The region between the original and functional squamo columnar 
junction is the zone of transformation in which active metaplasia of 
squamous epithelium occurs. It is the remodeled area of ectropion .Since 
it is very much dynamic, it is susceptible to changing hormonal and 
environmental influences. 
          This area is the one most susceptible to Human PapillomaVirus 
infection for several reasons, including higher susceptibility of the 
advancing edge of the immature squamous epithelium to infection. 
In 1975, for the first time, the WHO proposed unified terminology 
to describe and report cervical carcinoma precursor lesions in cervical 
biopsy specimens. Dysplasia was divided into mild, moderate and severe. 
It was considered a distinct entity from carcinoma in situ (CIS) in which 
the entire squamous epithelium was replaced by undifferentiated cells. 
In the 1980s, the International Society of Gynaecological 
Pathologist (ISGYP) introduced nomenclature that replaced the term 
“dysplasia” with Cervical Intraepithelial Neoplasia (CIN) and eliminated 
the category of carcinoma in situ. The CIN terminology was divided into 
three categories, CIN I, CIN II, CIN III, with CIS (Carcinoma in situ) 
being incorporated into the Cervical Intraepithelial Neoplasia  category. 
The Bethesda System which has been used for many years in the 
reporting of cervical cytology is most recently applied for reporting 
cervical lesions on biopsy specimens. 
       The Bethesda System is a two-tiered system, which divides dysplasia 
into LSIL (Low grade squamous intraepithelial lesion) and HSIL (High 
grade squamous intraepithelial lesion). 
       Now the single category of High grade squamous intraepithelial 
lesion incorporates both cervical intraepithelial Neoplasia-II and Cervical 
intraepithelial Neoplasia-III. 
       The Bethesda System also places condyloma acuminatum into the 
LSIL category whereas WHO and CIN terminology kept condyloma 
acuminatum as a separate category. 
        The biology of precursor lesions of carcinoma cervix is more closely 
reflected by the Bethesda System of classification. It also unifies the 
nomenclature used for reporting both cervical cytology and biopsy 
specimens.
8 
PRECURSOR  LESIONS  OF CERVICAL CANCER  
 CLASSIFICATION        
BASED ON DEGREE 
OF DYSPLASIA 
TERMINOLOGY 
ACCORDING TO 
WORLD HEALTH 
ORGANISATION. 
BETHESDA           
SYSTEM  
 
Mild dysplasia 
 
      CIN 1 
Low –grade 
squamous 
intraepithelial 
lesion(LSIL) 
 
Moderate dysplasia 
   
    CIN 2 
High –grade 
squamous 
intraepithelial 
lesion(HSIL) 
    
Severe dyplasia     
/carcinoma in situ 
     
 CIN 3 
High –grade 
squamous 
intraepithelial 
lesion(HSIL) 
*World Health Organization, Cervical Intraepithelial Neoplasia (CIN) 
LOW GRADE SQUAMOUS INTRAEPITHEIAL LESION (LSIL) 
Squamous intraepithelial lesions which are low grade  typically 
occurs  in women of reproductive age , with  the peak incidence  in the 
third decade as most young women are exposed to Human Papilloma 
Virus sometime after becoming sexually active.  
Three morphologic subtypes of Low grade squamous intraepithelial 
lesions are;  
1) Condyloma  acuminatum  
2)  Condyloma  -immature 
3) Condyloma -Flat 
 
 
 
 
 
 
 
 
 
 
 
CONDYLOMA ACUMINATUM 
                    The histology shows papillae which are blunt shaped with a blood 
vessel in its core, acanthosis and superficial koilocytic changes. 
Underlying cervical stroma shows chronic inflammatory cells. 
 
 CONDYLOMA-IMMATURE 
      The features seen are papillae which are slender lined by squamous 
epithelium showing little keratinocyte maturation and mild superficial 
koilocytic atypia. 
 
FLAT CONDYLOMA:  
It exhibits morphological features similar to condyloma 
acuminatum but the pattern of growth is not exophytic here. Upper third 
of the epithelium shows atypical changes in this lesion. 
 
 
 
 
 
HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION 
(HSIL):-  
                These occur at a slightly older age group then LSIL, with 
highest prevalence in women between 35 to 39yrs.The frequency of HSIL 
has increased in younger women over the past 20 years. The epithelium 
shows atypical nuclear features involving all the layers with a variable 
degree of surface maturation. 
             Cervical intraepithelial Neoplasia-II shows epithelial maturation 
and koilocytic changes in surface epithelium. In case of severe dysplasia 
/in situ carcinoma epithelial maturations is minimal or absent.
10
. 
             Cervical intraepithelial Neoplasia-III includes both severe 
dysplasia and carcinoma in situ.  
         According to an international committee held first on exfoliative 
cytology, carcinoma in situ is defined as a preinvasive lesion with a lining 
surface epithelium showing no differentiation at all levels of epithelium.
7 
       A more aggressive approach to the management of these lesions is 
warranted, because progression to invasive carcinoma occurs in a higher 
percentage of these lesions 
20
. 
 
INVASIVE CARCINOMA OF CERVIX:- 
                The cervix is the commonest site for female genital tract cancer 
and statistics vary considerably from country to country and from race to 
race. So in African and Asian women living in poor conditions, the 
incidence and relative mortality rate of the carcinoma cervix is 4-5 times 
higher than those seen in developed countries.
6, 11
 
         Carcinoma cervix is the second most common cancer in women 
worldwide next to breast cancer incidence. Cancer mortality statistics 
states that it is the third leading cause of death after lung and breast 
cancers. 
       Cancer of cervix is reported at all ages of women. Invasive squamous 
cell carcinoma is being diagnosed at two peaks one at about 35 years and 
another around 50-55yrs. 
AETIOLOGY 
Age 
Young sexually active women are at increased risk for Human Papilloma 
virus infection and preinvasive cervical intra epithelial Neoplasia.  This 
risk drops significantly with increasing age which is associated with 
increasing risk of cancer. Risk drops further with the approach of 
menopause. .
 
 Cervical Intra epithelial Neoplasia (CIN) occurs at a much lower age. 
One third of the cases being found in women less than 30 years old.
15, 16 
Religion and Race: 
The incidence of cervical cancer is less in women of Jews and 
Muslims due to ritual circumcision done at childhood in male children.  
Social and Economic Factors: 
Cervical carcinoma  is common in people living in low Socio 
economic status .They are very much more prone due to low standards of  
penile hygiene, early coitus,  frequency of sexual intercourse and 
promiscuity of both partners. 
Coitus: 
            Incidence of cancer is 4-5 times more common in sexually active 
women    than in sexually inactive women.    
Cervical Infection: 
Human papilloma virus plays an important role in virtually all 
cases of which type 16, 18, 31 and 45 accounts for 80% of cervical 
carcinoma. 
There are about 15-20 types of HPV acting as a cofactor in 
epithelial cancer of cervix. HPV 16 is associated with 50% of cases.
13,17 
 
Hormonal Factors:
 
There is some evidence that Estrogen- Progesterone Oral 
Contraceptive pill usage favours CIN changes and also for 
Adenocarcinoma. 
The other risk factors in epidemiology of cervical cancer include 
HIV infection, deficiency of vitamins, cigarette smoking and pregnancy 
at early age. 
Predisposing Histological Status: 
Certain histological changes in the cervix which are alleged to be 
“Pre cancerous” or which are sometimes confused with cancer include 
basal Cell hyperplasia, squamous cell metaplasia and CIN. Of these, only 
CIN-II and CIN III are likely to significant forerunners of invasive 
carcinoma.
18, 19
 
Histological Classification of Cancer Cervix: 
Carcinoma cervix nearly always starts at the squamo-columnar 
epithelial junction and 80-90% cases are squamous cell in type. 
  In 5-10% of cases it is entirely columnar cell in pattern  
(AdenoCarcinoma) and the frequency is increasing especially in young 
women who are smokers or pill-users. The remainder constitutes the 
mixed types. 
 
 
 
 
WHO Histological Classification -  The Uterine Cervix Tumors 
Epithelial Tumors 
 
Squamous tumors and precursors 
Squamous cell carcinoma, not otherwise specified 
             Non-   Keratinizing 
             Keratinizing 
             Papillary 
             Basaloid 
             Warty 
             Verrucous 
             Lymphoepithelioma –like 
             Squamotransitional 
Early invasive (micro invasive) squamous cell carcinoma 
 
Squamous intraepithelial Neoplasia 
        Cervical intraepithelial Neoplasia-3 (CIN3)   
        Squamous cell carcinoma in situ 
Benign squamous cell lesions 
Squamous papilloma 
Condyloma acuminatum 
Fibroepithelial polyp 
Glandular tumors and precursors 
Adenocarcinoma 
Mucinous adenocarcinoma 
Endocervical 
Intestinal 
Signet-ring cell 
   Minimal deviation 
Endometrioid adenocarcinoma 
Clear cell adenocarcinoma 
      Villoglandular 
      Serous adenocarcinoma 
      Mesonephric adenocarcinoma 
Early invasive adenocarcinoma 
Adenocarcinoma in situ 
Glandular dysplasia 
Benign glandular lesions 
Endocervical polyp 
Mullerian papilloma 
Other epithelial tumors 
Adenosquamous carcinoma 
Glassy cell carcinoma variant 
Adenoid cystic carcinoma 
Adenoid basal carcinoma 
Neuroendocrine tumors 
Carcinoid 
Atypical carcionoid 
Small cell carcinoma 
Large cell neuroendocrine carcinoma 
Undifferentiated carcinoma. 
Mesenchymal tumors and tumor – like conditions 
Leiomyosarcoma 
Endometrioid stromal sarcoma, low grade 
Undifferentiated endocervical sarcoma 
Sarcoma botryoides 
Leiomyoma 
Genital rhabdomyoma 
Alveolar soft part sarcoma 
Angiosarcoma 
Malignant peripheral nerve sheath tumor 
Postoperative spindle cell nodule 
 
Mixed epithelial and mesenchymal tumors 
Carcinosarcoma (malignant mullerian mixed tumors)  
Adenosarcoma 
Wilms tumor 
Adenofibroma 
Adenomyoma 
Melanocytic tumors 
Malignant melanoma 
Blue naevus 
Miscellaneous tumors 
Tumors of germ cell type 
       Dermoid cyst 
      Mature cystic teratoma 
      Yolk sac tumor 
Lymphoid and haematopoetic tumors 
Malignant lymphoma (specify type) 
Leukaemia (specify type) 
 
Secondary tumors. 
 
Reagan et al (1957) recognized three groups of squamous cell 
carcinoma
27 
  Non – Keratinizing type –large cell type (moderately 
differentiated grade ) 
  Keratinizing type- Large cell type ( well differentiated  grade ) 
 Small cell Non – Keratinizing type(poorly differentiated grade )  
Other variants of squamous cell carcinoma are  
 Papillary squamo transitional carcinoma 
 Verrucous carcinoma 
 Lympho epithelioma -like  
 Basaloid  
 Condylomatous (warty) 
 
MICROINVASIVE SQUAMOUS CARCINOMA:- 
               Mestwerdt was the first to introduce the concept of 
microinvasive carcinoma in 1847. In the progressive spectrum of 
squamous intraepithelial Neoplasia
25
 it is considered to be a stage which 
is preclinical.  It is a carcinoma that could be diagnosed only by 
histological examination. 
       It is defined as a tumour that must be identified only by examination 
by microscope. Invasion by tumour extends to a maximum depth of 
5mm and a maximum width of 7mm. 
 INVASIVE SQUAMOUS CELL CARCINOMA  
Worldwide squamous cell carcinoma of cervix is the second most 
common cancer in women after breast cancer. Squamous cell carcinoma 
is the most common cancer in women in developing countries 
Although previously accounting for >90% of all cervical cancers, 
the overall frequency has decreased due to the implantation and success 
of national cervical smear screening programs. This has also resulted in 
the detection of otherwise asymptomatic small, early invasive lesions.  
Squamous cell carcinoma of cervix has three variants
27
 
 Non –keratinising carcinoma which account for two thirds of 
cases show cytoplasmic keratinization of individual cells and 
intercellular bridges, but keratin pearls and nests of tumour cells 
with central keratin are not present. 
 Keratinizing  carcinoma which account for one –sixth of cases 
contain keratin pearls and nests of tumour cells with central 
keratin ; cytoplasmic keratinization and keratohyaline granules 
are also present and intercellular bridges can be identified. 
 Small cell non -keratinizing carcinoma  are characterized by 
sheets of smaller non-keratinized cells, with high nuclear 
cytoplasmic ratio. 
Epidermoid (squamous cell) carcinoma comprises the majority of 
cervical   carcinoma about 70%. The most common pattern is non-
keratinising large cell    type. It has better prognosis. 
Well –differentiated keratinizing epidermoid carcinoma constitutes 
about 25% of the cases .Undifferentiated carcinoma-small cell is less 
common and has a poor prognosis.  
   
Modification of Broder’s method28 –based on the extent of differentiation   
is 
  Well differentiated- Grade-1   
  Moderately differentiated- Grade-2   
   Poorly differentiated -Grade-3   
Most are grade-2, then 3 and then 1. 
Basaloid carcinoma have a basaloid  appearance with nests of  
tumour cells having less abundant eosinophilic cytoplasm and 
peripheral pallisading of nuclei. 
Verrucous carcinoma- extremely rare subtype is characteristically 
exophytic with little to no cytologic atypia. 
     Warty carcinoma is exophytic with surface koilocytic changes. 
Papillary carcinoma is characterized by papillary growth pattern and 
divided into – 
1) Papillary undifferentiated carcinoma 
      2) Papillary transitional cell carcinoma 
      3) Papillary squamo- transitional carcinoma 
 
 
Lymphoepithelial like:
9
- 
 It is characterized by ill defined islands of undifferentiated cells 
associated with marked lymphocytic background within the stroma. The 
tumour cells have a syncytial growth, poorly defined cell borders and 
moderate pale eosinophilic cytoplasm. 
Adenocarcinoma:  
Primary adenocarcinoma makes up 15% of all carcinoma cervix. 
It’s relative incidence is on the rise , particularly young women. An 
association has been found between long term use of OCP and the 
development of endocervical Neoplasia in young patients.
5 
        Most common pattern is that of a well differentiated glandular 
pattern with mucin secretion. 
Morphological variants 
 Endometriod adenocarcinoma 
 Papillary serous carcinoma 
 Adenosquamous (mixed carcinoma) 
 Adenoid cystic carcinoma 
 Adenoid basal carcinoma 
 Clear cell carcinoma 
Endometriod adenocarcinoma resembles its endometrial and ovarian 
counterparts.  There is an increasing incidence in this type carcinoma
 
Adenoma malignum is minimal deviation adenocarcinoma. 
Glucksmann and Cherry originally emphasized the importance of 
Adenosquamous carcinoma and used the term Mixed carcinoma.
7 
Mixed 
carcinoma combines pattern of adenocarcinoma with well defined 
squamous component.
 
        A distinct type of poorly differentiated adenosquamous carcinoma 
referred as glassy cell carcinoma occurs at an age group younger than 
cervical neoplasm. It has often been associated with pregnancy. 
       Clear cell carcinoma (mesonephric carcinoma)  is composed of 
glands in tubule-cystic, papillary pattern  with a  single  lining of cells 
having  large amount of  clear cytoplasm .The cells may show enlarged 
and pleomorphic nuclei protruding into the lumen giving a ‘Hob 
nail’appearance. 
Although it can occur in all age groups it is common in young females 
and the prognosis is relatively good. 
 
Mixed epithelial / Mesenchymal neoplasms: 
It includes: 
1. Endocervical polyp 
2. Adenomyoma 
3. Carcinosarcoma 
4. Cervical Adenosarcoma 
Adenosarcoma:  
      It is a biphasic tumour composed of a malignant stromal component 
and a benign epithelial component. Primary cervical adenosarcoma is 
extremely rare accounting for a minority (2%) of those that occur in the 
genital tract. 
 Melanocytic Tumours 
1. Blue nevus 
2. Malignant melanoma 
        Only 30 cases of malignant melanoma have been reported in the 
literature. It is a neoplasm which is very rare. The mean age of patient is 
in the sixth decade and the prognosis is poor. 
Neuroendocrine tumours 
The group of neuroendocrine tumours includes   
 
 Carcinoid 
 Atypical carcinoid 
 Large cell neuroendocrine carcinoma 
 Small cell carcinoma 
 
Carcinoid 
Benign carcinoids have characteristic organoid appearance as seen in 
other sites. The differential diagnosis between typical and atypical 
carcinoids is based on the atypia of nucleus and mitotic activity. 
 
Atypical carcinoid 
     Increased mitotic count (about 5-10 per high power field), areas of 
necrosis and cytologic atypia are features of atypical carcinoid. 
Small cell carcinoma 
This type of carcinoma account for 1-6% of cervical carcinoma. 
Squamous or glandular differentiation may be present. 
Large cell neuroendocrine carcinoma  
  It has features of high grade neoplastic cells with trabecular or insular 
pattern at least in a focal area. The tumour cells have vesicular chromatin, 
abundant cytoplasm, prominent nucleoli and high mitotic index (greater 
than 10 mitosis per 10 HPF). 
              Metastasis from neuroendocrine carcinoma, sarcoma- 
undifferentiated, neuroendocrine differentiation in adenocarcinoma are 
the differential diagnosis.  Markers like neuron specific enolase, 
chromogranin and synaptophysin are used in immunohistochemistry to 
show neuroendocrine differentiation. 
         The misery of women due to carcinoma cervix, which causes 
increased mortality in women is a scourge of humanity in a country 
developing like ours. 
        Best approach to achieve control over cancer cervix is early 
diagnosis and management of the intraepithelial lesions of squamous 
epithelium.  
      Cytological screening by Pap smear has brought down the incidence 
of cervical cancer in developed countries 
35
.Unfortunately cytology fails 
to identify high risk low grade SIL (LSIL) and high grade SIL (HSIL) 
which would progress to invasive cancers. Such information can be 
provided by a molecular tumor marker
36
.  One such molecular tumor 
marker is AgNOR which stands for silver stained (Ag) nucleolar 
organizer regions (NORs). 
 
 
NUCLEOLAR ORGANIZER region (NORS) 
Ribosomal RNA is encoded by the DNA loops present in the 
nucleoli of all cells. These are called the Nucleolar organizer region 
(NORS). 
The acrocentric chromosomes 13, 14, 15, 21and 22 showing 
secondary metaphase constrictions in their short arms are referred to as 
NORS. 
The technique of silver impregnation can be used to detect these 
regions which   are argyrophilic 
21
. 
Silver stainability or NOR is due to the presence of a peculiar set of 
acidic proteins , which are highly argyrophilic.
23   
.Binding of silver and 
protein occur in carboxyl and sulphydryl groups by colloidal precipitation 
of  ionic silver. The silver solution is reduced by the carboxyl groups 
forming micronuclei of silver. 
Deposition of large aggregates of silver occurs at the disulphide 
and sulphydryl groups. 
 
These  are visible by light microscope as black intra nuclear granules. 
The number of AGNOR in a cell nucleus reliably reflects the cell 
kinetics and proliferative activity.
22 
 
                     
Cell kinetics plays an important role in tumour behavior and 
proliferation. Rates of tumour proliferation can be assessed to determine 
the behavior of particular tumour.
14
  
  
The cell cycle can be divided  into four phases based on the nuclear 
chromatin activity .They are S,G1 G2 & G0 .The DNA content at the 
end of “S” phase is an indicator of proliferative activity and AGNOR 
detects the DNA content at this stage. 
 
 
STRUCTURE AND FUNCTION OF INTERPHASE NOR:- 
Ribosomal genes essential for biogenesis are present in the 
nucleolus which is a well defined functional and structural unit of the 
cell. 
 Three main components of the mammalian cell nucleoli apart 
from intranuclear chromatin are; 
1) The fibrillar center, appears as rounded structures of different 
size and is composed of very thin loosely, inter oven fibrils. 
2) Densely packed fibrils present at the periphery of the fibrillar 
center constitutes the dense fibrillar component. 
3) Fibrillar component is surrounded by granules which is the 
granular component.  
        Inter phase counterparts of metaphase NOR are the fibrillar centers 
and the closely associated dense fibrillar component 
24 
. Structural-
functional units for rRNA transcription are represented by the interphase 
NOR.   
 
        Ultra structural and immuno-cytochemical investigations in the 
interphase NOR revealed the presence two main enzymes RNA 
polymerase I and topoisomerase I controlling transcription. 
       The two main AgNOR proteins called as Protein B23 and Protein 
C23 plays a vital role in the control of transcription and processing of 
rRNA. 
37 
 
 
 
 
Interphase NOR and Nucleolar Pathology: 
Simple staining methods using the principle of silver impregnation 
identifies the proteins which are argyrophilic. These are AgNOR which 
stains as black dots in the nucleus. 
AgNOR content is expressed as mean AgNOR count for 50-100 
cells. After DNA synthesis, in the G2 phase of the cycle a diploid nucleus 
might contain 20 AgNOR. In practice the AgNOR are so closely packed 
and it is difficult to distinguish one AgNOR from another. The 
argyrophilia of the NOR associated protein (NORAPs) acts as marker of 
ribosomal DNA and reflects its transcriptional phase. The number of 
visible AgNOR therefore indicates the current phase of transcription
26
  
Ribosomal sequences of the chromatin is highly compact in resting 
cells whereas in proliferating cells progressive dispersal of ribosomal 
chromatin  occurs due to increased synthesis of AgNOR. 
Clinical management of cancer is based on the histopathological 
typing, grading and staging of tumours.  But clinical outcome in many 
cases has no significant correlation with the histopathological diagnosis. 
All possible markers of prognostic importance may not revealed by 
histopathological assessment. These problems have led to the 
development of newer techniques to be used as an adjunct to routine 
methods available. 
To improve the accuracy and reproduce the features of prognostic 
significance
29 
a new technique was introduced based on nuclear studies. 
This assesses tumour tissue by silver staining of the nucleolar organising 
regions (AgNOR).
 
There is significant high frequency of AgNOR dots within nucleus 
of malignant cells than in normal, reactive or benign neoplastic cell. 
Good correlation with other markers of proliferation, reasonable cost and 
simple procedure has made this technique popular.
31
 
Their potential value in diagnostic histopathology was they can be 
easily demonstrated in routinely processed tissue sections. 
   
 
The cell population in tissue sections shows an apparent increase in the 
mean AgNOR count if: 
1. Cell proliferation was so active and nucleolar dissociation was present 
in many cells, when the   AgNOR were seen throughout the nucleus.  
2. There was a defect of the nuclear association, resulted in AgNOR 
dispersion. 
3. There was an increase AgNOR following increased cell ploidy.  
4.Prominence of inconspicuous AgNOR as a result of increased 
transcriptional   activity. 
In a normal cell 20 black dots of AgNORs should be seen (2 per 
arm of chromosome i.e. (2x 10 = 20) but only one or two dots are seen as 
the dots are tightly packed 
34
. As we move from normal cells towards the 
dysplastic cells and malignant cells, the amount of DNA increases, and 
the number of AgNOR dots (AgNOR count) also increases.    
   
INTERPHASE AgNOR AND CANCER PROGNOSIS:- 
Until recently, at light microscopic level a precise evaluation of 
nucleolar morphology, and its change during cell activation or 
transformation was impossible to be performed in routine cytopathology 
and histology. 
Small nucleoli are usually undetected and large nucleoli, 
independent of their size and shape are generally defined as “Prominent”. 
In 1986, Ploton and co-worker applying the formic acid silver 
nitrate staining method for AgNOR proteins at the light microscopy level, 
succeeded in a very precise visualization of interphase NOR. 
Evaluation of interphase NOR which appear as well defined black 
dots is done by light microscopy and each dot correspond to one 
interphase NOR as visualized by the electron microscope.
24 
There is a definite relationship between the proliferative activity of 
cells and interphase AgNOR. Hence quantification of interphase 
AgNOR’s can be considered as a parameter of cell kinetics. The shorter 
the doubling time of cell the greater the amount of interphase AgNOR .
 38 
Ploton and co-workers have demonstrated that there is greater 
quantity of interphase AgNOR in malignant cells than the benign or 
normal cells and therefore evaluation of interphase AgNOR distribution 
may be useful for the diagnosis of malignancy
24  
  
The cell kinetic parameters may help clinical oncologists and 
pathologist to define the biological behaviors of cancer lesions, 
indications about specific treatments of cancer and valuable information 
of prognostic significance. 
    Previously stained cytology slides can be reused for silver staining  
providing an excellent guide to the diagnosis especially in doubtful cases 
and when unstained slides are not available. This is one of the great 
advantages of this silver staining technique. 
 
The major disadvantages are:  
1. Observer error is the major cause of inaccuracy and inconsistency  
2. The counting procedures adopted are usually manual and hence long 
and tedious. 
3. Overlap and coalescence may result in misjudged counts 26. 
 There has been a growing interest in the study of DNA and proliferation 
markers. One of the most recent studies is on Nucleolar Organizer silver 
reduction technic method.  
D C Rowlands
37
 (1988) was the first to study the number of nucleolar 
organising regions (NORs) among different grades of cervical 
intraepithelial lesions (CIN). 
A small but significant increase in the CIN-III group and no significant 
difference in the AgNORs in the  normal biopsy specimens of squamous 
epithelium  and those showing CIN-I and CIN-II were observed. 
Mark Egan et al
 36 
(1990)
 
studied the relationship between 
intraepithelial neoplasia of the cervix, and   the size and number of 
nucleolar organizer regions. They found that mean numbers of AgNORs 
identified steadily increased, whereas the mean sizes of AgNORs 
decreased from CIN I to CIN III. 
CIN III could be distinguished from CIN I and CIN II on the basis 
of AgNOR sizes, and an inverse relationship between AgNOR numbers 
and sizes was established. 
Darne et al
43
 (1990) in their study on AgNORs in normal 
endocervix, adenocarcinoma and in AIS observed a significant overlap 
between cases of invasive adenocarcinoma and Adenocarcinoma in situ 
(AIS). 
There was no overlap between the groups of normal endocervical 
cells and invasive adenocarcinoma. 
          This suggests that AIS is a precursor lesion of invasive 
adenocarcinoma. But histological subtypes of adenocarcinoma could not 
be differentiated using assessment of AgNORs.  
Yasuhiro Yokoyama et al
12
 (1990) in  their study on
    
Nucleolar 
organizer regions (NORs) in 70 cases of precancerous and cancerous 
lesions of the uterine cervix found that the mean number of AgNOR dots 
in the cases of mild dysplasia that progressed to CIS was 2.7. This was 
significantly higher than that in the cases that regressed. No correlation 
was noted between CIS and invasive carcinoma. 
Lakshmi et al
44
 (1993) observed a highly significant positive 
correlation between AgNOR counts and tumour progression in their 
AgNOR analysis done in CIN lesions and invasive squamous cell 
carcinomas. Maximum AgNOR counts were seen in invasive carcinomas.  
Kaushik R et al 
39
 (1995)studied   hundred cases of cervical lesions 
including normal, chronic cervicitis, CIN (I, II, III) and carcinoma to 
assess the utility of AgNOR counts in differentiating cervical lesions. 
Statistical counts of AgNORs were done. The mean AgNOR counts in 
cervical epithelium showed a progressive and statistically significant 
increase from normal to chronic cervicitis to CIN I, II and III (P<0.001). 
Scores in carcinoma also exceeded that of CIN (P<0.05). 
D Prathiba et al 
24
 (1995) analysed AgNOR count in premalignant 
and malignant lesions of cervix and found statistically significant 
difference in these lesions. They also found that marked disaggregation of 
AgNORs occurs in small cell carcinoma of cervix indicating very high 
proliferative activity and poor prognosis.  
Jyothima Agarwal et al
46 
(1997) counted AgNORs in biopsies from 
various lesions of cervix. The mean of AgNORs per nucleus was 
significantly higher in CIN (4.05±0.04) and malignancy (5.50±0.65) as 
compared to squamous metaplasia (1.74±0.32) and chronic cervicitis 
(1.54±0.42). Adenocarcinoma had higher counts compared to other 
carcinoma. 
Pillai et al 
45
 (1998) in their study observed that increased 
proliferative activity may be a positive indicator of prognosis i.e. tumours 
with high AgNOR counts and Ki67 index responded better to 
radiotherapy. Pre-treatment biopsies from 152 squamous cell carcinoma
 
  
patients were evaluated for Ki67 expression and AgNOR counts to
 
relate 
the disease outcome after radiotherapy.  
Murty et al
59
 in their study found that  not only the count  of NORs 
increases in carcinoma cervix  but also they become  more prominent and 
larger in size  appearing as giant size.   
Kari J.Syranen et al 
41 
(2001) were the first to analyse the 
prognostic significance of AgNOR in 85 cases of squamous cell cancer of 
cervix with known HPV status.
42
  Significant correlations of AgNOR 
counting and quantitation with tumour proliferation and progression in 
cervical squamous cell carcinoma was found. 
Ritu Singhal et al
50
 (2003) found that in squamous cell carcinoma 
cervix the AgNOR counts were higher when compared to glandular 
carcinoma of cervix. 
     Pahuja S et al
51
 (2003) studied the proliferative potential of squamous 
intraepithelial lesions in fifty biopsy sections of various grades of 
preinvasive and invasive squamous epithelial lesions of cervix by 
AgNOR staining. AgNOR counts showed progressive rise in their mean 
value with increasing grade of lesion. Amongst invasive malignancies, 
highest mean of AgNORs were observed in poorly differentiated 
squamous cell carcinoma of cervix. 
They concluded that proliferation potential of squamous 
intraepithelial lesions of cervix is the main factor affecting the biological 
aggressiveness of the lesion. 
Kafil Akhtar et al
47
 (2005) conducted a study on 50 histologically 
proven, previously untreated cases of different grades of squamous cell 
carcinoma of the cervix. The patients were subjected to Cobalt-60 
radiotherapy and  pap smears obtained 4 and 8 weeks after therapy were 
assessed for AgNOR score. 
  AgNORs in carcinoma of the cervix prior to radiotherapy were 
large and variable in size and shape and after radiotherapy showed 
multiple AgNOR dots which were fewer in number and less coarse as 
compared to the pre-radiation group.  In patients who showed persistence 
of malignancy, the AgNOR dots were found to be coarse and present in 
large clumps. 
Singh Uma et al 
48
 (2006) observed in  their 
 
AgNOR  study  of  43 
histologically proven cases of CIN that mean AgNOR count per cell was 
more in CIN II than that in CIN I and more in CIN III than that in CIN II. 
They concluded that AgNOR count can be used as an adjunct to histology 
for diagnosing CIN especially in doubtful cases. 
  Vijaya V Mysorekar et al
49
 (2008) reviewed two hundred 
specimens of benign and malignant squamous epithelial lesions of the 
cervix   to study the utility of proliferative and apoptotic indices .They 
found that both indices combined are useful to differentiate between 
benign, preinvasive and invasive squamous epithelial lesions of the 
cervix.   
They concluded that the prognosis and plan of management in 
cases of cervical lesions can be determined by mitotic count, AgNOR 
count and apoptotic count which are the simplest techniques that can be 
employed in any laboratory.  
Luz del Carmen Alarcón-Romero et al
66
 studied about the AgNORs 
polymorphisms in squamous intraepithelial lesions (SIL) and squamous 
cell carcinoma (SCC) with HPV infection. They found that according to 
the grade of histological lesions AgNORs polymorphism rises 
progressively. It is a useful prognostic indicator. 
KC Shiva Raj et al
40
 (2012) studied the role
 
of AgNOR in 
differentiating non-neoplastic and precursor lesions from neoplastic 
lesions in both cervical smears and histology by conducting a prospective 
study.
 
  
They found that the number and shape of AgNOR dots change 
from benign to precancerous to malignant tumors and AgNOR Pattern 
Assessment is useful in differentiating benign to intraepithelial lesions to 
carcinoma cases.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIAL  AND METHODS 
Total 62 female patients were studied, out of them 57 were of 
cervical pathology and 5 were used as normal controls. Detailed 
histological examination in hematoxylin and eosin was done along with 
the AgNOR studies. The AgNOR score was then evaluated in relation to 
the histological diagnosis. 
This is a prospective study that included biopsy specimens of 
benign, pre-malignant and malignant squamous epithelial lesions of 
cervix. 
 
INCLUSION CRITERIA 
These included cervical biopsies done for diagnostic evaluation, as well 
as surgical specimens resected as a therapeutic measure. 
 
EXCLUSION CRITERIA 
* Biopsies showing extensive ulceration of the cervical squamous 
epithelium were excluded from the study. 
* Sections not showing adequate epithelial cells for counting were 
also excluded.  
* Tumours with extensive necrosis and scanty viable tissue were also 
excluded. 
Single step AgNOR staining technique
52
 was employed on 3microns 
thick paraffin sections for demonstration of AgNORs. 
Silver nitrate method for AgNOR protein sites (after Ploton et 
al    1986) 
Sections: 
Formalin –fixed, 2-3-µm paraffin sections. 
Solutions: 
50% silver nitrate solution 
Silver nitrate -50g 
Distilled water - 100ml 
Gelatin solution 
Gelatin -2g 
Formic acid -1ml 
Distilled water -100ml 
 
WORKING SOLUTION 
Silver nitrate solution 2 parts by volume 
Gelatin solution 1 part by volume 
 
Mix in above proportion immediately before use, the volume of working 
solution used depends on the number of slides to be stained. 
 
 
STAINING METHOD 
1. Dewax sections in xylene, hydrate through ethanol to water. 
2. Rinse sections in distilled water. 
3. Incubate in freshly prepared working solution for 30-40 min at 
room temperature. 
4. Wash in distilled water for 1min. 
5. Dehydrate , clear, and mount in non-aqueous mounting medium. 
RESULTS 
AgNOR sites   -intranuclear black dots 
Background    -yellow 
 
OBSERVATION AND RESULTS 
Of 2136 gynecological specimens received at pathology 
department Coimbatore Medical College Hospital during the period 
August 2011-July 2012, cervical intraepithelial Neoplasia was reported in 
12cases and malignant lesions of cervix in 229 cases. 
      This prospective study included routinely processed biopsies from 
62 patients with various lesions of the cervix diagnosed histologically 
during the period August 2011-July 2012. 
According to the cancer statistics 2011at Pathology department 
Coimbatore Medical College Hospital, the incidence of malignancies in 
the female reproductive system is as follows Cervix 19%,Breast 
7%,Uterus 1.5%, Vulva 1% and Vagina 0.5% . 
 
 
 
 
 
 
 
The incidence of malignancies in the female reproductive system in 
given in the following chart. 
 
 
AGE INCIDENCE 
           The patients initially diagnosed as Cervical Intra epithelial 
Neoplasia and Cervical cancer were divided into 7 groups according to 
age (ie; 21-30, 31-40,    41-50, 51-60, 61-70, 71-80, 81-90). There was 
increased incidence of Cervical cancer observed in the age group of 51-
60years (32.8%) followed by 41-50 years (27.9%) and 61-70years 
(18.4%). 
The age wise distribution of cervical cancers is given in the 
following Table-1 & chart-1 
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TABLE-1 
S.NO AGE GROUPS NO OF CASES PERCENTAGE 
1.           21-30              7          3.05% 
2.           31-40            29          12.7% 
3.           41-50            64          27.9% 
4.           51-60            75          32.8% 
5.           61-70            42          18.4% 
6.          71-80             9            3.9% 
7.           81-90              3            1.3% 
      
 
 
 
 
 
 
 
 
 
 
  
AGE WISE DISTRIBUTION OF CERVICAL CANCER, 
CHART -1 
 
 
 
Cervical Intra epithelial Neoplasia (CIN) occurs at a much lower 
age. One third of the cases being found in women less than 30 years old.
16
  
In the present study Cervical intraepithelial Neoplasia constituted about 
0.4% of various lesions of cervix and most of the cases were in the age 
group 31-40yrs followed by 51-60yrs.  
 
 
 
0 
5 
10 
15 
20 
25 
30 
35 
21-30 31-40 41-50 51-60 61-70 71-80 81-90 
3.05% 
12.7% 
27.9% 
32.8% 
18.4% 
3.9% 
1.3% 
P
e
rc
e
n
ta
ge
 
Age 
The age wise  distribution of Cervical Intraepithelial Neoplasia is given in 
the following Table-2. 
                                  TABLE-2 
S.NO AGE GROUP NO.CASES   
 LSIL 
 NO.CASES 
HSIL 
1. 21-30         
2. 31-40     4(CIN I) 1 
3. 41-50          1(CIN I) 1 
4. 51-60  2 
5. 61-70           1*
 
1 
6. 71-80  1 
7. 81-90   
     0.2%  0.2% 
1* condyloma acuminatum 
 
 
 
 
 
The following Table -3 shows the distribution of cervical cancers 
according to differentiation. 
                                               TABLE-3 
 
S.NO 
       GRADE      
NO.CASES 
  
Percentage 
1. Well 
differentiated 
         8       3.2% 
2. Moderately 
differentiated 
 
        192        91.8% 
3. Poorly 
differentiated 
         9         4.3% 
                                                                                                                              
In this study most of the cases are moderately differentiated (192cases 
91.8%) followed by poorly differentiated squamous cell carcinoma 
(9cases 4.3%).Well differentiated carcinoma constitute 3.8% of total 
cases. 
 
 
 
The following Table-4 shows distribution of cervical cancers (squamous 
cell carcinoma) according to morphological subtypes  
 
                                             TABLE-4 
S.No Morphological 
subtypes 
     No of cases   Percentage 
1. Non keratinizing 
SCC 
          192      90.9% 
2.  Keratinizing SCC             8      3.8% 
3. Small Cell SCC            9       4.3 % 
4. Papillary squamo-
transitional 
carcinoma 
 
           3       1.4% 
 
 
 
 
 
The following Table -5 shows distribution of Glandular and other cervical 
neoplasm :- 
                                                  TABLE-5 
S.No Morphologic  No of 
cases  
 Percentage 
1 Adenocarcinoma      10    4.3% 
2  Clear cell 
adenocarcinoma  
      
       2 
   0.8% 
3 Adeno squamous         3    1.3% 
4 Adeno sarcoma         1    0.4% 
5 Malignant 
melanoma 
       1    0.4% 
 
In 229 cases of cancer cervix most of the cases are Non-keratinizing 
squamous cell carcinoma(192cases), Keratinising squamous cell   
carcinoma (8cases), Small cell(9)cases, Papillary squamo   
transitional(3cases), Adenocarcinoma(10cases). Clear cell 
adenocarcinoma(2cases), Adenosquamous(3cases), Adenosarcoma(1case) 
and Malignant melanoma (1 case). 
 
 In this study 10 cases of Non Keratinizing squamous cell 
carcinoma, 8 cases of Keratinizing squamous cell carcinoma, 9 cases of 
small cell Non Keratinizing squamous cell carcinoma, 8 cases of 
Adenocarcinoma were subjected to AgNOR study. 
This study also included 5 control of normal cervical mucosa, 10 
cases of chronic cervicitis with squamous metaplasia and 12 cases of 
cervical intraepithelial Neoplasia to evaluate AgNOR count in benign, 
premalignant and malignant lesions of cervix. 
The present study was undertaken in the Department of Pathology, 
Coimbatore Medical College Hospital, Coimbatore. 
A total of 62 cases of various lesions of cervix during the period 
August 2011-July 2012 were subjected to AgNOR study. 
 
These were broadly classified into 8 groups according to their 
Histopathological  reports as shown below in (Table 6.) 
 
 
 
Table :6 Histopathological classification of cervical lesions :- 
 
S.No  
   
                     Groups 
 
Subdivision 
I Histopathological normal  cervical mucosa  
 
 
Benign 
 II Chronic cervicitis with squamous metaplasia  
III LSIL (condyloma,CIN I,CIN II) Premalignant 
 IV HSIL(CIN III-Carcinoma in situ) 
V SCC(well differentiated)  
Malignant  
 
VI SCC (Moderately differentiated ) 
VII SCC (Poorly differentiated ) 
VIII Others* 
* includes adenocarcinoma and its variants. 
The biopsy specimens which were received were subjected to 
routine paraffin sectioning at 3 μm thickness after proper fixation in 10% 
formal saline. AgNOR staining was performed by the procedure 
described
52 
by Ploton et al
 .  
 The sections were deparaffinized in xylene and hydrated through 
decreasing grades of ethanol to double distilled deionized water.  
  The sections were then reacted with freshly prepared silver 
colloidal solution   (1 part by volume of 2% gelatin in 1% formic acid and  
two parts by volume of 50% aqueous silver nitrate solution)  for 35 min at 
room temperature,  ensuring  that a dark environment was maintained 
throughout the reaction  time. 
  The silver colloidal solution was washed with double distilled 
ionized water, dehydrated through increasing grades of alcohol, cleared in 
xylene and mounted. 
AgNOR Counting Procedure 
The number of AgNORs which were present in each nucleus was 
counted in 100 nuclei by using a 100x oil immersion lens. At this 
magnification, AgNORs are visible both within and outside the nuclei 
52
. 
The mean AgNOR values were calculated for each case and group. The 
results which were obtained in the counting procedure were analyzed 
statistically by using the Student’s t-test, one way analysis of variance 
(ANOVA) for intergroup comparisons and Post hoc test -LSD  (Least 
Significant Difference) for multiple comparison. 
 
   
 The mean AgNOR count of the  studied groups was as follows :  
TABLE :7 
Groups    No 
Cases 
mAgNOR 
SD 
I  5 1.63 .10 
II 10 1.61 .11 
III 6 2.83 .19 
IV 6 3.78 .16 
V 8 4.55 .26 
VI 10 5.25 .06 
VII 9 7.20 .11 
VIII 8 6.13 .04 
 
The groups I & II (control subjects and benign lesions), could be 
differentiated clearly, based on the low value of the mAgNOR counts 
from the groups IV – VII.  Group III and group IV differed from groups 
V-VIII, based on the value of the mAgNOR counts, which helped to 
demarcate between the pre-malignant and the malignant lesions of the 
cervix and hence, helped to formulate the treatment plan for the patient, 
on whether a conservative approach or surgery was required. 
 
     
 mean AgNOR count in the studied groups- CHART 2 
 
Groups V, VI and VII, VIII observed a significantly higher mean 
difference for the AgNOR count with all the rest groups. This indicated 
that squamous cell carcinomas of cervix and adenocarcinoma could be 
differentiated from the pre-malignant and benign lesions, based on the 
mAgNOR count also.  
The total 37 cases of squamous cell carcinoma in our study were 
further graded into three grades according to the increasing number of the 
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AgNOR dots (as shown in [Table8] and according to their morphology 
into well, moderately and poorly differentiated carcinomas.  
 
 
Table :8  mAgNOR count according in different   grades of  tumor  
Grade  No of 
cases 
 MAgNOR S.D 
I 8 4.55 0.26 
II 20 5.25 0.06 
III 9 7.20 0.11 
 
The value of the mean AgNOR count for the three grades of 
squamous cell carcinoma  of cervix in the present study were found to be  
4.55 ± 0.26,5.25 ± 0.06 and 7.20 ± 0.11 respectively (as shown in  
[Table8]. The mean AgNOR count showed a linear and significantly 
increasing trend as the histopathological grade of the  tumour increased 
(p<0.01)-chart -3 Study of mAgNOR count according to grade of tumor 
(squamous cell carcinoma)  
  
 mAgNOR count in different grades of tumour - CHART-3 
 
In the present study, it was observed that the AgNOR dots were 
large, homogenously stained and regular in the nuclei of the normal 
cervical mucosa, chronic cervicitis with squamous metaplasia, whereas 
significant differences (irregular, giant and bizarre clusters) were seen in 
the squamous cell carcinomas.  
In the malignant squamous cells, they appeared to be less uniform 
in size and shape and some dots appeared to be clumped together to form 
irregular bizarre shaped clusters ,which were more obvious in the 
moderately and poorly differentiated squamous cell carcinomas. Hence, 
by seeing the number and morphology of the AgNOR dots, squamous cell 
carcinomas of the cervix could be graded into well differentiated, 
moderately differentiated and poorly differentiated grades, which would 
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further help in the assessment of the prognosis of the lesion and hence, 
the outcome . 
As shown in the [Table 9) intergroup comparison was done among 
8 groups for the statistical analysis, which were divided by using the 
ANOVA test. The value was found to be statistically significant among 
the various comparative groups     (p < 0.01) except between group I and 
group II. 
There were no significant difference in AgNOR count between 
normal cervix and inflammatory lesions of cervix in the present study, 
hence insignificant p value (p>0.05).  
 
 
 
  
Comparison of mAgNOR count between various groups using 
ANOVA 
TABLE - 9 
Groups Statistically significant 
difference  with group 
p value 
(less 
than)* 
    Not 
significant 
difference 
with group 
p value 
(more 
than) 
I       III,IV,V,VI,VII <0.01 II >0.05 
II       III,IV,V,VI,VII <0.01 --       -- 
III I,II,IV,V,VI,VII <0.01 --       -- 
IV I,II,III,V,VI,VII <0.01 --       -- 
V I,II,III,IV,VI,VII <0.01 --       -- 
VI I,II,III,IV,V,VII <0.01 --       -- 
VII            I,II,III,IV,V,VI <0.01 --        -- 
VIII I,II,III,IV,V,VI,VII <0.01 --        -- 
 
*  Significant p value  
 
 
 
 
COLOUR PLATES   
 
A: Normal squamous epithelium of ectocervix H&E STAINING (10X) 
 
Fig 1B: AgNOR STAIN of Normal squamous epithelium of cervix mucosa showing 
homogenously stained and regular 1-2 AgNOR dots in the nuclei-(40x) 
 
 Fig 2A: Condyloma acuminatum showing superficial koilocytic changes (10X) 
 
 
Fig 2B: AgNOR STAIN of condyloma acuminatum showing AgNOR dots in the 
nuclei(40X) 
 Fig 3A: Keratinising Squamous cell carcinoma -Well differentiated H&E (10X) 
 
 
Fig 3B: Well differentiated squamous cell carcinoma  -  AgNOR STAIN   (40x) 
 Fig 4A: Moderately differentiated squamous cell carcinoma H&E stain10X 
 
 
Fig 4B: AgNOR stain Moderately differentiated squamous cell carcinoma 
showing  3-4 AgNOR dots. 
 Fig 5A :Squamous cell carcinoma –poorly differentiated grade H&E 
(10X) 
 
Fig 5B: Poorly differentiated squamous cell carcinoma showing 
numerous irregularly shaped AgNOR dots dispersed in the nuclei 
 Fig 6A: Well differentiated Adenocarcinoma H&E (10X) 
 
 
Fig 6B : AgNOR staining of well differentiated Adenocarcinoma showing 
numerous AgNOR dots 
 Fig 7A: Clear cell adenocarcinoma showing Hob nail cells  H&E (10x) 
 
 
Fig 7B  Pattern of AgNOR staining in Clear cell adenocarcinoma 
 
 
 
 
 Fig 8A: Adenosquamous carcinoma showing both adeno and squamous epithelial 
components. (H&E-10X) 
 
 
Fig 8B : Pattern of AgNOR staining in Adenosquamous carcinoma 
 
 Fig 9A: Adenosarcoma-Biphasic tumour composed of benign glandular epithelial 
element and malignant stromal component 
 
 
Fig 9B: Malignant stromal component of Adenosarcoma showing irregular bizarre 
and giant AgNOR  dots 
 
 Fig 10A:Papillary squamo transitional carcinoma (H&E-10X) 
 
 
Fig10B: Pattern of AgNOR staining in papillary squamo transitional carcinoma 
 
 
 
 
DISCUSSION 
Cervical carcinoma is the second most common cancer women 
worldwide with increased mortality in about half of the new cases 
reported each year. 
There has been increasing incidence of invasive cervical cancer 
and deaths from cancer cervix according to a recent estimate by cancer 
Society at America.  
More than 80 percent of all cases of cervical cancer occur in 
developing countries. 
Cervical cancer rates are lower in young women but increases with 
age. Due to the high prevalence of human papilloma virus infection 
around the age of 25 years the cancer incidence increases with age. 
      The risk of developing cancer cervix increases with age due to 
persistence of  HPV infection.
42 
Routine effective screening before the age of 65 has reduced the 
incidence of cervical cancer .Above the age of 65 years cases of cervical 
cancer constitutes more than 20%.  
In the present study the youngest age group at which cervical 
cancer was reported is 25yrs. Its incidence is common between 51-60 
years followed by  41-50years. 
  According to the observation in literature the mean age for LSIL 
and HSIL was 3rd to 4th decade 
68 
 
  In the present study the mean age for LSIL and HSIL was 38 years 
and 53.3  years respectively .Data from the cancer registries indicate 
that more than 75% of cervical cancers develop in women above the 
age of 35 years
67
. 
        In the field of tumour histopathology demonstration of nucleolar 
organizer regions (AgNOR) by one stage argyrophilic method is proving 
to be a useful staining procedure as a morphological indicator of 
prognosis. 
The current phase of transcription is reflected by the size and the 
number and of NOR dots in the cells. It is significantly different in 
malignant cells from that in normal or benign cells. The NORs stains as 
black dots in the nucleus in the AgNOR method. 
 The squamous and columnar epithelial cells of cervix may show 
regenerative and repair changes following chronic infection and radiation 
therapy. They include marked cellular atypia with enlarged 
hyperchromatic nuclei, coarse chromatin and macronucleoli. Irregular 
nuclear membrane and nuclear pleomorphism may be seen but absent 
mitotic activity. 
 These doubtful changes are sometimes misdiagnosed as cancer. The 
AgNOR technic proves to be a useful index of cell proliferation.  
 
AgNOR method:   
      In this study, sections were cut at 3-4 microns thickness and fixed in 
10% formalin. Visualization of the AgNOR dots were good with thin 
tissue sections.
54,55 
 
AgNOR counting: - 
  In this counting method, the number of interphase AgNORs which 
appear as well defined black dots are evaluated under light microscope. 
Each dot corresponds to one interphase NOR as visualized by electron 
microscopy. 
Using the method suggested by Crocker et al
56,62
 enumeration of 
AgNOR dots were done.Sampling of tissue, processing and staining 
procedures greatly influences evaluation of AgNOR dots. It is highly 
subjective and only solution to these problems is by standardization of the 
procedure.  
        Another choice for Agnor quantification is by image cytometry 
which has high degree of precision, reproducibility, with minimal inter-
observer errors. Cytogenetics which applied the AgNOR staining 
technique earlier has gained importance now as an indicator of 
proliferative activity of the cell. 
          AgNORs are usually indiscernible in normal cells because of the 
tight packing of nucleoli in the nucleus. Dispersion of individual 
AgNOR’s occurs in rapidly proliferating neoplastic cells due to nucleolar 
disaggregation.  
The present study was conducted to evaluate the    importance of 
AgNORs in differentiating benign, pre-malignant and malignant lesions 
of the cervix. 
  For routine evaluation of cell kinetics for prognostic purposes, 
interphase AgNOR quantification appears to be very interesting and 
promising  method. 
In routinely processed samples it is the only method which permits 
information to be obtained on the rapidity of cell proliferation. The 
method more frequently employed involves evaluation of the sample 
directly at the light microscope and counting the number of interphase 
AgNOR per cell. By carefully focusing throughout the section thickness 
at very high magnification (100 x oil immersion level) AgNORs are 
visible as black dots inside the nucleus. Numerous AgNOR dots were 
seen in poorly differentiated tumours. 
Crocker et al who have done intensive work on NOR’s in various 
tumors have observed three main types of AgNOR configurations in 
normal and neoplastic cells.
56
 . 
The following are the NOR patterns observed   
  The NOR’s are fully aggregated to form a solitary rounded 
structure,often seen in resting cell.  
  Nucleolar pattern in proliferating cells, where NOR’s can be 
seen within the nucleus. 
  Dispersion of small NOR’s throughout the nucleoplasm as 
frequently observed in highly malignant cells. 
             It was observed in the present study that the AgNOR dots were 
large and regular in the nucleus of the normal cervical mucosa and 
chronic cervicitis whereas irregular and giant were seen in squamous cell 
carcinomas and adenocarcinoma of cervix. 
The mean AgNOR count of the normal cervical mucosa in the 
present study was 1.63 ± 0.10.The values are comparable with previous 
studies which were done by Prathiba et al (1.2), Ramsden et al (1.31),  
Kafil Akhtar (1.81).  
Observation of AgNOR count  by  Cullimore et al57   in normal 
squamous epithelium correlated well with the present study. 
KC Shiva Raj et al 
40
evaluated the role of AgNOR in 
differentiating benign and premalignant lesions from malignant lesions in 
both cervical  smears and histology in 53 cases. 
They found that in all benign lesions like chronic cervicitis and 
chronic cervicitis with squamous metaplasia AgNOR counts were  less 
than 2. In low grade squamous intraepithelial lesions AgNOR counts fall 
between 2.22 and 3.26  in cervical smears whereas in high grade 
intraepithelial lesions it was between 3.16 and 3.70 . In carcinoma cases it 
ranged from 4.5 to 5.58. 
In the present study the mAgNOR counts for chronic cervicitis 
with squamous metaplasia, LSIL, HSIL was 1.61±0.11, 2.83±0.19 and 
3.78±0.16 respectively. 
Significant increase of AgNOR counts was noted from CIN-I to 
CIN-III to carcinoma cervix but not significant difference in AgNOR 
counts was noted between normal cervix control and chronic cervicitis 
with squamous metaplasia. This observation was in accordance with the 
observations of Egan et al 
36
. 
  AgNOR shape also varied in benign lesions, precancerous and 
malignant cases. In LSIL; the majority of the dots were homogenous 
symmetric and had regular contours. In case of carcinoma, the dots were 
asymmetric and had irregular contours. They were aggregated, smaller 
and more scattered whereas, in HSIL the AgNOR dots morphology were 
having intermediate picture. The percentage of aggregated dots and 
scattered dots increases as the disease progresses.40  
Egan, et al 
36 
observed that mean AgNOR count increased steadily 
whereas the mean size of AgNORs decreased from CIN I to CIN III.  
     Cardillo 
34,65
 studied AgNOR counts in cervical smears of 
squamous metaplasia and cervical intraepithelial neoplasia.  Previously 
stained  Papanicolaou smears  were destained and restained with AgNOR 
silver. 
   In the present study statistically significant difference (P<0.05) in 
AgNOR counts were found in squamous metaplasia and various grades of 
CIN. 
An Indian study done by Pratibha and Kuruvilla
24 
 on the role of 
AgNOR in diagnosis of premalignant and malignant lesions of the cervix, 
showed there was a progressive increase in mean AgNOR count from 
normal to CIN I, CIN II, CIN III and invasive carcinoma.  
The difference between counts in CIN I and II and in normal cervix 
and between counts in CIN III and in invasive carcinoma in this study 
was statistically significant 
24
.  
In the present study it was also noted that the size of AgNOR dots 
decreased with increase in AgNOR count. This is in accordance with the 
study reported by Egan et al 
36 who noted an inverse relationship between 
AgNOR numbers and sizes, and proved that CIN III could be 
distinguished from CIN I and II on the basis of AgNOR sizes. AgNOR 
counts can thus be useful in differentiating doubtful cases of CIN. 
AgNOR counts also have prognostic significance. It has been noted 
that CIN lesions with low AgNOR counts are more likely to regress in 
comparison to CIN lesions with high AgNOR counts
36
 
However Rowland 
37
 in a study on nucleolar organizing regions in 
cervical intraepithelial neoplasia, did not find any significant difference in 
AgNOR count in squamous epithelium of normal cervix, CIN I and          
CIN II but there was a small but significant increase in CIN III group.  
Although there is variation in AgNOR counts in different studies 
the difference is statistically signficant in various grades of CIN in all 
studies except in the study reported by Rowlands 
37
. 
       S. Lakhmi et al 44 in their study observed a  significant  positive 
correlation  between AgNOR counts and tumor progression .They 
evaluated  AgNOR counts in inflammatory lesions of the uterine cervix, 
cervical intra-epithelial neoplasia, and invasive cervical squamous 
carcinoma. Significant differences in AgNOR counts were observed 
between the three study groups, with maximum counts in invasive 
carcinoma of cervix.
. 
In the present study AgNOR counts were also compared in the 
different grades of squamous cell carcinoma of the cervix. A progressive 
significant increase in the counts was observed with increasing grades of 
carcinoma. 
Counts of 4.55 ± 0.26 were recorded in well-differentiated 
carcinoma while moderately and poorly differentiated carcinomas yielded 
counts of 5.25± 0.06 and 7.20 ± 0.11 respectively. The difference was 
statistically significant (P <0.01) between well differentiated, moderately 
differentiated and poorly differentiated carcinomas. These findings 
strongly support the view that proliferative activity and malignant 
potential of neoplastic lesions of the cervix increase progressively as the 
grade of the lesion becomes higher.  Similar statistically significant 
AgNOR scores were obtained by Miller et al
64
 in cases of well 
differentiated squamous cell carcinoma of the cervix and poorly 
differentiated cases. 
Prathiba and Kuruvilla
24
  reported a mean AgNOR count of 4.3 in 
large cell keratinizing type (moderately differentiated) squamous cell 
carcinoma whereas AgNORs in the small cell type (poorly differentiated) 
were dispersed as very fine dots making the score difficult to ascertain. 
 Their study also recorded that AgNOR count increased with increasing 
grade of malignancy while Newbold et al
58
 failed to demonstrate any 
association between tumor grade and AgNOR count. 
However, Agarwal and Gupta
46
 have reported a mean AgNOR 
score of 5.27 ± 0.10 and 5.41 ± 0.72 in well differentiated and poorly 
differentiated squamous cell carcinoma respectively. This is not in 
agreement with the present observation. 
 Pahuja S et al
51
 in their study   analysed the cellular proliferative 
activity in squamous intraepithelial and invasive lesions of cervix   in 50 
cervical biopsies.  They found that amongst invasive malignancies, 
highest mean of AgNORs per nucleus was observed in poorly 
differentiated squamous cell carcinoma of cervix. In conclusion, 
AgNORs can prove to be a simple inexpensive and reliable proliferation 
marker in lesions of cervix.  
Kafil Akhtar  et al 
47
 in their  study subjected 50 histologically 
proven, previously untreated cases of various grades of  squamous cell 
carcinoma of the cervix  to Cobalt-radiotherapy .They found that AgNOR 
scores could differentiate between different grades of malignancy, high 
counts indicating a higher grade, while significant decline in AgNOR 
counts after radiotherapy denotes a good prognosis. 
  AgNOR is an effective tool reflecting the proliferation rate of the 
tumor and has a significant diagnostic and prognostic value in tumor 
pathology 
According to Murty et al
59
 in carcinoma cervix not only the 
number of NoRs become more prominent and larger in size, many  times 
appearing giant size . This finding was in accordance to the present study.
 
There was also a significant increase in NOR from grade I to grade 
III Carcinoma. This correlated well with the study by Murty et al
59
. 
Degree of differentiation and transcriptional activity
60 
was reflected by 
AgNORs position particularly ectopic AgNOR or abnormal distribution. 
          During this study several technical problems interfered with the 
staining method .They are duration of the staining, the temperature, the 
purity of water and the reagents. The above factors influenced the final 
result to a great extent.  
 Particular attention was paid to the cleanliness of the glassware and 
the purity of water in order to avoid background staining and non-specific 
granular deposits on the tissue sections 
69
. 
         With adequate efforts  made to standardize the tissue processing and 
the staining techniques the silver staining technic in diagnostic pathology 
has achieved a new milestone. 
53 
The AgNORs have been shown to reflect DNA transcriptional activity. 
Study of AgNORs has been identified as a reliable indicator of cell 
proliferation and in turn, of the malignant potential of a lesion 
24
. 
Malignant tumor cells are characterized by extremely large AgNORs, 
which show a random or scattered distribution. They are useful in 
discriminating between benign and malignant conditions being 
significantly higher in neoplastic cells than in normal cells 
61,63
. They also 
serve as a significant prognostic indicator in malignant lesions 44.  
The AgNOR technic which was earlier used extensively in 
cytogenetics  has now gained importance as an indicator of cell 
proliferation. AgNOR scores differentiate between different grades of 
malignancy, high counts indicating a higher grade, while significant 
decline in AgNOR counts after radiotherapy denotes a good prognosis.  
            A correlation between the AgNOR count and prognosis was too 
found in colorectal cancer, benign and malignant effusions, adenoid 
cystic carcinoma
 
and breast carcinoma. It is of prognostic value also in 
ovarian cancer transitional cell carcinoma of the bladder and glottic 
cancer.
32 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION AND SUMMARY 
1. The incidence of cancer cervix is 19%  of all malignancies in 
various organs received for histopathological examination at 
Coimbatore medical college Hospital.  
2. Squamous cell carcinoma of cervix constitutes 92.5% of cervical 
cancers .Most of the cases were Non-keratinizing squamous cell 
carcinoma and Moderately differentiated grade. 
3. Cervical cancers are common between the age group of 51-60 
years  
4. In the present  study, it was observed that the AgNOR dots were 
large, homogenously stained and regular in the nucleus of the 
normal cervical mucosa and chronic cervicitis with squamous 
metaplasia whereas significant differences (irregular, giant and 
bizarre clusters) were seen in squamous cell carcinomas and 
adenocarcinoma of cervix 
  The misery of women due to cervical cancer, which is the 
commonest cancer in women in a developing country like ours is a 
scourge of humanity. 
Early diagnosis and management of squamous intraepithelial 
lesions (SIL) is the best  way to achieve control over cancer cervix. 
Of the various newer techniques based on nuclear studies,  
assessing the tumour  by staining of AgNORS using a silver compound 
has become popular for its 
 Simple procedure 
 Easy use 
 Reasonable  Cost 
  Correlation with other markers of proliferation 
  
The present study also shows an inverse relationship between 
AgNORs number and their size . There was a  continuous increase in 
AgNORs from normal to carcinoma along with decrease in size of 
individual AgNORs. 
As a marker of cellular activity as well as malignancy, AgNOR 
count can be utilized for discriminating benign, precancerous and 
cancerous lesions. It is also useful in differentiating the atypical changes 
in regenerating epithelium, postmenapausal atropic mucosa, and 
following radiation therapy. These lesions are usually misdiagnosed as 
cancer by histopathological examination.    
AgNOR count is a reproducible simple efficient and inexpensive 
method which can be used as an adjunct to routine cytology and 
histopathology for diagnosis of Cervical Intraepithelial Neoplasia 
especially in doubtful cases. 
  Studies have reported that dysplasia with low AgNOR counts are 
more likely to regress as compared to those with high AgNOR counts 
which on the other hand are likely to progress to invasive cancer showing 
its prognostic significance.       
Thus, the AgNOR technique can be useful as a supportive tool in 
the prognosis and therapeutic decision in squamous cell carcinomas to the 
routinely performed haematoxylin and eosin staining. 
       The staining procedure is simple and cost effective. But to achieve 
good results  a lot of dedication, standardization and meticulous bench 
work is needed.Therefore AgNOR quantify can be considered only as 
one, among the other well  established  cyto-histopathological parameters 
to be used for diagnosis of malignancy. 
In conclusion, AgNORs can prove to be a simple inexpensive and 
reliable proliferation marker in lesions of cervix and can be a used as a 
supplementary factor for the difficult  histoprognostic evaluation of 
various malignancies. 
 
 
                                DEPARMENT OF PATHOLOGY  
               COIMBATORE MEDICAL COLLEGE AND HOSPITAL  
                                        COIMBATORE  
 
                                      PROFORMA 
IP NO:                            HPE NO : 
Patient  Name :  
Age:                    IP/OP :                     Religion & Caste: 
Occupation:                                              S.E. Status: 
Address: 
Clinical diagnosis: 
1) PRESENTING COMPLAINTS: 
A) Bleeding per vagina  
Amount : Heavy(   )          Moderate(    )               Scant(    )            
Variable(    ) 
Duration:                Intervals.                  
Episodes of intermenstrual bleeding : Yes (   )          No (   ) 
Duration:                                    Days. 
B)History of dysmenorrhoea :  Yes(   )    No(   ) 
C) History of  White discharge :  Yes(   )   No(   ) 
II) OBSTETRIC HISTORY: 
Married Life:                                Para:   
Abortion : Yes(   )   No(   )             No of Abortion: 
Last Delivery :                     Tubectomy :  Yes(   )  No(   ) 
III) MENSTRUAL HISTROY: 
Age of Menarche:                   Years. 
Menstrual Cycle : Regular (    )     Irregular (   ) 
Duration  of the cycles:              Days  
Amount of Bleeding : Heavy(   )    Moderate (    )  Scant(   ) 
History of dysmenorrhoea :Yes(   )      No(   )  
Others : 
 
Previous Menstrual History : 
Interval :            Days ,Duration of  bleeding :                         
Amount : Heavy(   )    Moderate(   )    Scant(   )     Variable(   )  
History of  Dysmenorrhoea :  Yes(   )    No(   ) 
History of white Discharge :   Yes (   )   No(    ) 
Last Menustrual Period : 
IV ) PERSONAL HISTORY : 
Appetite : Good(   )          Reduced(   )  Variable(   ) 
Bowel Habits : Regular(   )     Irregular(    )  Variable(   )  
Micturition frequency   
Burning Micturition : Present(    )          Absent(   )  
Other Abnormality : 
Vegetarian (    )                     Non vegetarian (    )                    Mixed (   ) 
V) HISTORY OF ANY DISEASE: 
History of  Tuberculosis :        Yes(   )          No(    ) 
History of Diabetes Mellitus : Yes(   )           No (   ) 
History of Hypertension :        Yes(   )           No (   ) 
History of  Endocrine Disease (Thyroid ) : Yes(    )    No (    )  
History of Bleeding Disorder: Yes(    )     No  (   ) 
History of any other major illness ( specify) : 
 History of any Drug intake (specify): 
 
VI) FAMILY HISTORY : 
Diabetes (    )           Tuberculosis (    )    Hypertension(    ) 
Obesity(   )    Malignancy  (   )  
Other ( specify): 
 
VII) GENERAL EXAMINATION : 
Built and Nourishment : Poor (    )   Moderate (    )  well(   )    Obese(   ) 
Height :                              Weight :                            Pulse    /Min  
Blood Pressure :   mmHg.                       Anaemia : Yes(   )     No(   ) 
Jaundice : Yes (   )   No(  )   Lymphoadenopathy: Yes(    )       No(   ) 
Oedema : Yes(    )    No (   ) 
VIII) SYSTEMIC EXAMINATION: 
Cardiovascular System : 
Respiratory system : 
Per abdomen : 
Liver : Enlarged(   )     Normal (    ) 
Spleen : Enlarged (   )  Normal(   )  
Operation Scar : Present (    )          Absent(     )  
Mass : Palpable (     )     Not Palpable(   )  
Other (specify) 
Breast : 
Thyroid : 
Skin : 
Central Nervous System : 
IX ) Local E xamination  
Vulva : Healthy (     )  Unhealthy (    ) 
Other (specify) 
Bleeding : Present(    )         Absent (    )   
Per Vaginal Examination: 
Cervix : Direction : 
Consistency : 
Bleeds on Touch : Yes(   )  No(    )  
Cervical Erosion : Present(     )    Absent (    ) 
Other (specify ): 
Uterus : Anteverted (    )     Retroverted(    ) 
Normal Size  (    )             Bulky (     )    Small (     )  
Mobile          (     )            Fixed    (     ) 
X) LABORATORY INVESTIGATIONS: 
1) URINE : Albumin: 
Sugar : 
Microscopy: 
Other Abnormalities (If any ): 
2) HEAMATOLOGY : 
Heamoglobin:       gms/dl . 
RBC Count :          Millions /cu.mm. 
Total  Leukocyte Count :        / cu.mm 
PCV :       %  ,          MCV:        fl 
MCH :       pg          MCHC     gms % 
Differential Count :  
Platelet count : /cu.mm E.S.R ;   mm/hr  
Blood Group & Rh Typing :   
Bleeding Time :                         Clotting Time : 
Peripheral Blood Picture : 
 
3) BIOCHEMICAL TESTS: 
Random Blood Glucose :  mg/dl 
Blood Urea :   mg/dl 
4) RADIOLOGICAL INVESTIGATIONS: 
Ultrasonographic findings: 
Others(specify): 
5) BIOPSY : 
(Diagnostic Dilatation & Curettage Of  Endometrium 
Finding during D&C (if any) 
 Cervix Biopsy    :  
 Gross Appearance: 
 Microscopic  Appearance: 
 
METHOD OF HEMATOXYLIN AND EOSIN STAINING 
Reagents used; 
1. Erhlich s Hematoxylin solution 
2. Eosin Y solution 1% 
3. Acid Alcohol solution 1% 
Procedure: 
1.Deparrafinize the sections 
2.Immerse the sections in xylene for 30 minutes 
3.Then place in isopropyl alcohol for 15 minutes 
4.Wash in tap water 
5.Stain the sections with Erhlich s Hematoxylin or 10-15 minutes 
6.Wash in tap water 
7.Differentiate in 1% acid alcohol solution-2 to 3 dips 
8.Blueing for 10 minutes 
9.Counterstain with 1% eosin solution 2-3 dips 
10.Wash in tap water 
11.Air dry the sections 
12.Xylene -Mount  
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MASTER CHART 
S 
NO  
HEP NO AGE   SEX IP NO SPECIMEN TYPE HPE DIAGNOSIS 
 
AgNOR 
COUNT 
mAgNOR 
COUNT 
SD 
1 G1124/11 54  F 205321 HYSTERECTOMY 
C X- NORMAL 
HISTOLOGY 
1.5 
1.63 0.1 
2 G1132/11 50  F 216689 HYSTERECTOMY 
CX -NORMAL 
HISTOLOGY 
1.6 
3 G1155/11 45  F 230519 HYSTERECTOMY 
CX -NORMAL 
HISTOLOGY 
1.6 
4 G1158/11 52 F 232129 HYSTERECTOMY 
CX-NORMAL 
HISTOLOGY 
1.75 
5 G1163/11 49 F 207803 HYSTERECTOMY 
CX-NORMAL 
HISTOLOGY 
1.7 
6 G1245/11 44 F 229485 CERVIX BIOPSY CRC WITH SM 1.5 
1.61 0.11 
7 G1284/11 50 F 235843 CERVIX BIOPSY CRC WITH SM 1.6 
8 G1295/11 53 F 229718 CERVIX BIOPSY CRC WITH SM 1.6 
9 G1298/11 46 F 38785 CERVIX BIOPSY CRC WITH SM 1.75 
10 G1334/11 48 F 252250 CERVIX BIOPSY CRC WITH SM 1.7 
11 G1431/11 58 F 253975 CERVIX BIOPSY CRC WITH SM 1.4 
12 G1477/11 56 F 251586 CERVIX BIOPSY CRC WITH SM 1.7 
13 G1493/11 43 F 265880 CERVIX BIOPSY CRC WITH SM 1.6 
14 G1530/11 49 F 274184 CERVIX BIOPSY CRC WITH SM 1.7 
15 G1542/11 54 F 49827 CERVIX BIOPSY CRC WITH SM 1.5 
16 G1873/11 35 F 408170 CERVIX BIOPSY LSIL 2.6 
2.83 0.19 
17 G1979/11 38 F 396951 CERVIX BIOPSY LSIL 2.6 
18 G2024/11 40 F 46640 CERVIX BIOPSY LSIL 2.9 
19 G2041/11 36 F 47542 CERVIX BIOPSY LSIL 2.9 
20 G2066/11 48 F 458487 CERVIX BIOPSY LSIL 3 
21 G972/12 70 F 451127 CERVIX BIOPSY CDA 3 
22 G255/12 75 F 7142 CERVIX BIOPSY CIS  3.75 
3.78 0.16 
23 G1306/11 45 F 41452 CERVIX BIOPSY CIS  3.75 
24 G1441/11 65 F 30515 CERVIX BIOPSY CIS  3.8 
25 G1950/11 39 F 64607 CERVIX BIOPSY CIS  3.75 
26 G2034/11 58 F 455787 CERVIX BIOPSY CIS  4.05 
27 G2038/11 54 F 446175 CERVIX BIOPSY CIS  3.55 
28 G36/12 60 F 258710 CERVIX BIOPSY ISCC-LS -K-WD 4.15 
4.55 0.26 
29 G128/12 60 F 107738 CERVIX BIOPSY ISCC-LS -K-WD 4.55 
30 G380/12 72 F 108235 CERVIX BIOPSY ISCC-LS -K-WD 4.15 
31 G399/12 50 F 113552 CERVIX BIOPSY ISCC-LS -K-WD 4.66 
32 G431/12 82 F 12940 CERVIX BIOPSY ISCC-LS -K-WD 4.68 
33 G925/12 45 F 170643 CERVIX BIOPSY ISCC-LS -K-WD 4.65 
34 G971/12 47 F 206829 CERVIX BIOPSY ISCC-LS -K-WD 4.88 
35 G1005/12 58 F 235249 CERVIX BIOPSY ISCC-LS -K-WD 4.66 
36 G1/12 43 F 69525 CERVIX BIOPSY ISCC-LC-NK-MD 5.21 
5.25 0.06 
37 G9/12 60 F 3148 CERVIX BIOPSY ISCC-LC -NK-MD 5.32 
38 G22/12 42 F 8946 CERVIX BIOPSY ISCC-LC -NK-MD 5.32 
39 G38/12 37 F 10761 CERVIX BIOPSY ISCC-LC -NK-MD 5.19 
40 G64/12 30 F 2199 CERVIX BIOPSY ISCC-LC -NK-MD 5.19 
41 G67/12 50 F 20557 CERVIX BIOPSY ISCC-LC -NK-MD 5.21 
42 G99/12 47 F 29665 CERVIX BIOPSY ISCC-LC -NK-MD 5.2 
43 G102/12 50 F 29058 CERVIX BIOPSY ISCC-LC -NK-MD 5.32 
44 G127/12 42 F 3109 CERVIX BIOPSY ISCC-LC -NK-MD 5.2 
45 G141/12 55 F 1482 CERVIX BIOPSY ISCC-LC -NK-MD 5.32 
46 G185/12 27 F 11324 CERVIX BIOPSY ISCC-PD  7.15 
7.2 0.11 
47 G594/12 50 F 21732 CERVIX BIOPSY ISCC-PD  7.1 
48 G700/12 65 F 8556 CERVIX BIOPSY ISCC-PD  7.36 
49 G701/12 60 F 208454 CERVIX BIOPSY ISCC-PD  7.01 
50 G839/12 42 F 34289 CERVIX BIOPSY ISCC-PD  7.16 
51 G177/11 65 F 57766 CERVIX BIOPSY ISCC-PD  7.29 
52 G1844/11 65 F 404874 CERVIX BIOPSY ISCC-PD  7.16 
53 G1366/11 50 F 44485 CERVIX BIOPSY ISCC-PD  7.29 
54 G2064/11 55 F 458487 CERVIX BIOPSY ISCC-PD  7.36 
55 G1541/11 75 F 326715 CERVIX BIOPSY Adeno CA-MD 6.14 
6.13 0.04 
56 G1603/11 42 F 339147 CERVIX BIOPSY Adeno CA-MD 6.21 
57 G1644/11 65 F 57746 CERVIX BIOPSY Adeno  CA- MD 6.1 
58 G98/12 48 F 476511 CERVIX BIOPSY Adeno  CA-WD 6.14 
59 G1259/11 50 F 37314 CERVIX BIOPSY Adeno Squamous CA 6.06 
  
60 G1363/11 60 F 272035 CERVIX BIOPSY Adeno Squamous CA 6.1 
61 G849/11 67 F 35536 CERVIX BIOPSY Clear cell Adeno CA 6.21 
62 G785/12 45 F 234584 CERVIX BIOPSY Clear cell Adeno CA 6.14 
          
 
Key to Master Chart 
      
 
Cx  : Cervix 
      
 
CRC : Chronic Cervicitis 
    
 
SM : Squamous Metaplasia 
    
 
LSIL : Low Grade Intra Epithelial Lesion 
    
 
CDA : Condyloma Acuminatum 
    
 
ISCC : Invasive Squamous Cell Carcinoma 
    
 
WD                  : Well Differentiated  
    
 
MD : Moderately Differentiated  
    
 
PD : Poorly Differentiated  
    
 
LC : Large Cell 
    
 
K  : Keratinising 
    
 
NK : Non – Keratinising 
    
 
CARCINOMA : Carcinoma  
    
                                                 ABSTRACT 
       Study of nucleolar organiser regions (AgNOR) by silver staining technique has 
been found to be a reliable indicator of cell proliferation and in turn the malignant 
potential of a lesion.The objective of this study was to evaluate the role of AgNOR 
in differentiating benign and precancerous lesions from cancerous lesions in 
cervical biopsy specimens. 
This was a prospective study done at Pathology department Coimbatore Medical 
college Hospital during the period August 2011-July 2012 .AgNORs were counted 
in biopsies of various lesions of cervix from 62 patients. The mean number of 
AgNOR per nucleus was significantly higher in cervical intraepithelial neoplasia 
and carcinoma as compared to chronic cervicitis with squamous metaplasia and 
normal cervix. This method can be useful as an adjunct to histopathology in 
diagnosing doubtful cases. 
 
KEY WORDS:    AgNOR, Squamous metaplasia, cervical intra epithelial 
neoplasia, cervical carcinoma 
